Results 221 to 230 of about 3,320,695 (338)

IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets

Allergy, EarlyView.
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco, Syed B. Ali, Baran Erman, Safa Baris, Harshita Pant, Pravin Hissaria, Yelda Bilginer, Damon J. Tumes, Gökhan Cildir   +8 more
wiley   +1 more source

Feasibility of blood self-sampling with HemaSpot HF for Anti-Clostridium tetani Toxin IgG detection. [PDF]

Sci Rep
Kettlitz R, Ortmann J, Kerrinnes T, Ott JJ, Castell S.   +4 more
europepmc   +1 more source

Passive immunisation of hamsters againstClostridium difficileinfection using antibodies to surface layer proteins [PDF]

, 2005
Julie O’Brien, Matthew S. McCabe, Verà nica Athié-Morales, G. S. A. McDonald, Déirdre B. Ní Eidhin, Dermot Kelleher   +5 more
openalex   +1 more source

Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort

Acta Paediatrica, EarlyView.
ABSTRACT Aim To determine relationships between paediatric use of acid‐suppressive medications (ASMs) (proton pump inhibitors (PPI) and histamine‐2 receptor antagonists (H2RA)) and preschool body mass index (BMI) and mediation by C. difficile colonisation. Methods ASMs were parent‐reported at age 3, 6 and 12 months in 1025 infants from the CHILD Cohort
Sarah L. Bridgman, Kelsea M. Drall, Amanda A. Lau, Hein M. Tun, Nadia P. Morales‐Lizcano, Hien Q. Huynh, Piushkumar J. Mandhane, Theo J. Moraes, Elinor Simons, Stuart E. Turvey, Padmaja Subbarao, James A. Scott, Anita L. Kozyrskyj   +12 more
wiley   +1 more source

An Epidemiological Survey of Sepsis in a Tertiary Academic Hospital from Southwestern Romania. [PDF]

Medicina (Kaunas)
Grigorescu A, Dumitrescu F, Dorobantu S, Dragos A, Pirvu A, Roskanovic M, On Behalf Of The Fuse Study, Streata I, Ioana M, Netea MG, Riza AL.   +10 more
europepmc   +1 more source

Experimental infections with rifampicin-resistantClostridium perfringensstrains in broiler chickens using isolator facilities

, 2003
Karl Pedersen, Lotte Bjerrum, Birgitte Nauerby, Mogens Madsen   +3 more
openalex   +1 more source

Clostridium difficile Infection among Health Care Workers Receiving Antibiotic Therapy [PDF]

, 2005
Lisa M. Arfons, Amy J. Ray, Curtis J. Donskey   +2 more
openalex   +1 more source

Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation

Alimentary Pharmacology &Therapeutics, EarlyView.
In liver transplant recipients with coexistent inflammatory bowel disease, incidence of infectious events observed between those exposed to ‘gut‐specific’ and ‘systemic’ biologics were similar. Biologic choice should not be influenced by concerns regarding their co‐prescription with transplant immunosuppression.
Simone Chin, Danny Con, Patrick Hilley, Crispin Corte, Ken Liu, Adam Testro, Peter De Cruz, Matthew C. Choy, Ashish Srinivasan   +8 more
wiley   +1 more source

Emergency department eosinophil counts and mortality in Clostridium difficile: a multihospital retrospective cohort study. [PDF]

Porto Biomed J
Bella S, Laterza C, Biggs D, Walsh B, Gaudio C, Pacitto D, Silverman ME.   +6 more
europepmc   +1 more source

Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.

Clinical Microbiology and Infection, 2013
J. Kim, J. Kang, Heejung Kim, Mi-Ran Seo, T. Choi, H. Pai, E. Kuijper, I. Sanders, W. Fawley   +8 more
semanticscholar   +1 more source